VKTX News and Press, Viking Therapeutics Inc. From 05/24/24

2024-05-24 06:30:00 ET Things aren't so bad for investors right now. We are in a bull market even though the economy is still having some problems. However, this bull run won't last forever. There will be a slowdown, equities will fall, and many won't deliver anything approaching decent ret...

2024-05-20 07:02:27 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The Russell 2000 is a stock market index comprised of 2,000 companies that have small market capitalizations. A small-cap stock is generally any security of a publicly traded company wh...

2024-05-18 11:18:53 ET Summary Roche's obesity candidate CT-388 showed positive results in a phase 1b trial, with an 18.8% placebo-adjusted weight loss at week 24. The full data presentation is needed to assess safety and tolerability and how CT-388 stacks up against key competito...

2024-05-18 06:47:00 ET If you go to California's Redwood National Park, you can see the world's tallest tree -- a redwood called Hyperion that's over 380 feet tall. Like every other tree, though, Hyperion started as a small seed. Stocks can be like this, beginning small but growing to a...

2024-05-17 14:15:51 ET Summary Roche's acquisition of Carmot Therapeutics and their obesity drug CT-388 showed promising Phase 1b results, boosting Roche's stock by 4%. CT-388 demonstrated significant weight loss but lacked detailed safety data, making comprehensive evaluation cha...

2024-05-16 15:15:03 ET Raymond James analyst issues STRONG BUY recommendation for VKTX on May 16, 2024 01:43PM ET. VKTX was trading at $69.81 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 4 - Buy recomm...

2024-05-16 15:00:04 ET Joon Lee from Truist Financial issued a price target of $120.00 for VKTX on 2024-05-16 13:44:00. The adjusted price target was set to $120.00. At the time of the announcement, VKTX was trading at $69.525. The overall price target consensus is at $7...

2024-05-16 13:37:18 ET More on Viking Therapeutics What Makes Viking Therapeutics An Attractive Takeover Target Or Big Pharma Partner Viking Therapeutics: The Metabolic Masterpiece Primed To Be Acquired Viking Therapeutics, Inc. (VKTX) Q1 2024 Earnings Call Transcrip...

2024-05-13 10:00:00 ET Viking Therapeutics (NASDAQ: VKTX) has been one of the few bright spots in the healthcare sector this year. The biotech's shares have stormed higher by almost 300% year to date on the back of its midstage weight-loss candidate, VK2735. The lowdown is that ...

2024-05-13 08:15:00 ET Viking Therapeutics (NASDAQ: VKTX) isn't a household name, but if its plans to commercialize a powerful anti-obesity medicine come to fruition, it may well become one. Though it has yet to commercialize a drug, unlike its primary big pharma competitors, the da...